Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance

by Farzana Ahmed, Nikolas K. Haass, Nikolas K. Haass
Published 2018-05-01

The Role of Melanoma Cell-Stroma Interaction in Cell Motility, Invasion, and Metastasis

by Robert J. Ju, Samantha J. Stehbens, Nikolas K. Haass, Nikolas K. Haass
Published 2018-11-01

Fluorescence-Based Quantitative and Spatial Analysis of Tumour Spheroids: A Proposed Tool to Predict Patient-Specific Therapy Response

by Loredana Spoerri, Gency Gunasingh, Nikolas K. Haass
Published 2021-05-01

Editorial: Recent Developments in Therapies and Diagnostic Tools for Melanoma and Non-melanoma Skin Cancer

by Taku Fujimura, Yasuhiro Fujisawa, Atsushi Otsuka, Nikolas K. Haass
Published 2020-11-01

Switching the Sphingolipid Rheostat in the Treatment of Diabetes and Cancer Comorbidity from a Problem to an Advantage

by Nikolas K. Haass, Najah Nassif, Eileen M. McGowan
Published 2015-01-01

Modeling Melanoma In Vitro and In Vivo

by Kimberley A. Beaumont, Nethia Mohana-Kumaran, Nikolas K. Haass
Published 2013-12-01

Expression of Integrin Alpha10 Is Induced in Malignant Melanoma

by Ann-Kathrin Wenke, Christian Kjellman, Evy Lundgren-Akerlund, Christian Uhlmann, Nikolas K. Haass, Meenhard Herlyn, Anja K. Bosserhoff
Published 2007-01-01

Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay.

by Eileen M McGowan, Nikki Alling, Elise A Jackson, Daniel Yagoub, Nikolas K Haass, John D Allen, Rosetta Martinello-Wilks
Published 2011-01-01

Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression

by Martina Proctor, Jazmina L. Gonzalez Cruz, Sheena M. Daignault-Mill, Margaret Veitch, Bijun Zeng, Anna Ehmann, Muhammed Sabdia, Cameron Snell, Colm Keane, Riccardo Dolcetti, Nikolas K. Haass, James W. Wells, Brian Gabrielli
Published 2021-07-01

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine

by Zay Yar Oo, Martina Proctor, Alexander J. Stevenson, Deborah Nazareth, Madushan Fernando, Sheena M. Daignault, Catherine Lanagan, Sebastian Walpole, Vanessa Bonazzi, Dubravka Škalamera, Cameron Snell, Nikolas K. Haass, Jill E. Larsen, Brian Gabrielli
Published 2019-07-01

NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF

by Mitchell E. Fane, Yash Chhabra, David E.J. Hollingsworth, Jacinta L. Simmons, Loredana Spoerri, Tae Gyu Oh, Jagat Chauhan, Toby Chin, Lachlan Harris, Tracey J. Harvey, George E.O. Muscat, Colin R. Goding, Richard A Sturm, Nikolas K. Haass, Glen M. Boyle, Michael Piper, Aaron G. Smith
Published 2017-02-01